The Risk Comparison Between Large Enterprises and SMEs on Chinese Pharmaceutical Industry Based on the Solvency Indicators

The development of Medium and small enterprises (SMEs) in China are facing many difficulties to overcome its economic contradictions and problems. Financing will bear the brunt. As the SME’s own characteristics, which is small and the controllable resources are scarcer, often are growing rapidly, and require large capital investments. The current situation of SME financing is not good. The paper contributes using the basic method of statistical analysis of variance according to the research on financing difficulties of SMEs in relation to their business risks. Firstly the solvency indexes reflect the businesses are illustrated. Secondly, the paper introduces the basic principles of variance analysis and homogeneity of variance test and variance analysis of multiple comparisons. Finally the use of SPASS on the pharmaceutical industries’ solvency targets is analysed through the financial indicators related to SMEs’ finance difficult situation verified whether the risk of their operations has a significant impact.